Health
newsGP – Mixed response to latest Solidarity trial COVID findings – RACGP
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
News
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
While the results were disappointing, some experts say more detailed research is required. (Image: AAP)
Pre-print interim results from Solidarity, the world’s largest randomised control trial on COVID-19 therapeutics, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens have little or no effect on 28-day mortality or…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General22 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Noosa News12 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?